OtherGrowthDirectGrowthModerate

UTI Long Term Advantage Fund Series VII

Q: What is the NAV of UTI Long Term Advantage Fund Series VII?

The last published NAV of UTI Long Term Advantage Fund Series VII was ₹13.18 per unit, on 24 Sep 2021. The scheme has not published a NAV since then — it has likely been merged, wound up or discontinued, so this figure is historical, not a current price.

Q: What are the top holdings of UTI Long Term Advantage Fund Series VII?

UTI Long Term Advantage Fund Series VII's largest holdings are HDFC Bank Ltd (10.0%), Bharti Airtel Ltd (7.1%), ICICI Bank Ltd (7.1%), State Bank of India (6.5%) and ITC Ltd (6.0%). Holdings are disclosed monthly and change over time.

Q: How risky is UTI Long Term Advantage Fund Series VII?

UTI Long Term Advantage Fund Series VII is rated moderate on SEBI's risk-o-meter and its worst peak-to-trough fall in our sample was -42.6%. Higher volatility means the NAV swings more; the drawdown shows how far it has fallen from a peak historically.

Q: What is the benchmark of UTI Long Term Advantage Fund Series VII?

UTI Long Term Advantage Fund Series VII is benchmarked against the BSE 200 Total Return Index. Its alpha and beta on this page are measured against that index.

Q: How is UTI Long Term Advantage Fund Series VII taxed?

UTI Long Term Advantage Fund Series VII is an equity-oriented fund, so its capital gains get concessional rates: short-term gains (units held under 1 year) are taxed at 20%, and long-term gains (held 1 year or more) at 12.5% above a ₹1.25 lakh per-year exemption. These rates apply on redemption and don't add to your income-tax slab.

UTI Mutual Fund

This is the Direct plan of UTI Long Term Advantage Fund Series VII — bought from the fund house, with no distributor commission in its expense ratio. Income is retained in the fund, so it shows up as NAV rather than as a payout.

NAV

₹13.18

as of 24 Sep 2021

Compare SIP calculator

This scheme hasn’t published a NAV since 24 Sep 2021 — it appears to have been discontinued or merged. Trailing return and risk metrics need recent pricing, so they can’t be computed; only the NAV history and lifetime drawdown are shown below.

Performance

+50.81%CAGR

52-week rangePrev NAV ₹13.18

Latest ₹13.18

Low ₹8.53100th percentile of its 52-week rangeHigh ₹13.18

Scorecard

Not rated

How this is computed

Each verdict is computed from this fund's own metrics against its sub-category — the number behind it is shown, not a black-box rating. Not rated — this fund has no full year of NAV history yet. A rating needs at least a 1-year return to rank its performance against peers.

Performance—

Not enough Growth peers to rank yet

Risk—

Volatility not available yet

Cost—

Expense ratio not available yet

ConsistencyHigh

100% of rolling 3Y windows were positive

Strengths & concerns

Generated from this fund's own numbers against its sub-category — each point names the figure behind it.

Strengths

Consistent — positive in 100% of rolling 3-year windows

Concerns

No significant concerns identified.

Key Metrics

Annual fee charged by the fund, already deducted from NAV

Category —

Portfolio-weighted harmonic mean P/E across the fund's equity holdings

Category —

Excess return per unit of total volatility (rf = 6.5%)

—

Category —

Scheme Info

Definitions

Plan

Direct · Growth

Period before units can be redeemed — 3 years for ELSS, none for most open-ended funds

Exit Load

Statutory levy on every mutual-fund purchase since 1 Jul 2020 (SEBI / Govt of India) — the same for every scheme

0.005%

SIP Inv.

Smallest recurring SIP instalment the scheme accepts

Smallest one-time (lumpsum) investment the scheme accepts

Benchmark

Start of our NAV history for this plan. Direct plans begin 1 Jan 2013, so this is the plan's inception — not necessarily the scheme's original launch date.

28 Mar 2018

Period returns (<1Y, absolute — not annualized)

Definitions

Absolute return over the last 1 month (not annualized)

—

Absolute return over the last 3 months (not annualized)

—

Absolute return over the last 6 months (not annualized)

—

Absolute return since 1 Jan of this year (not annualized)

—

Annualized returns (≥1Y — CAGR)

Definitions

1-year point-to-point return, annualized (CAGR)

—

3-year annualized return (CAGR)

—

5-year annualized return (CAGR)

—

10-year annualized return (CAGR)

—

Annualized return (CAGR) since the fund's inception

—

Advanced metrics — risk and benchmark ratios

Risk (trailing 3Y)

Definitions

Annualized standard deviation of daily returns

—

Excess return per unit of total volatility (rf = 6.5%)

—

Excess return per unit of downside deviation — upside swings aren't penalized (rf = 6.5%)

—

Largest peak-to-trough decline over full history

-42.62%

Benchmark ratios (vs Nifty 500 · 36 monthly returns)

Definitions

Jensen's alpha (annualized): return above what CAPM predicts for the fund's beta vs Nifty 500

—

Sensitivity to Nifty 500 moves; 1 = moves with the index

—

How much of the fund's movement Nifty 500 explains

—

Excess return per unit of beta (market risk)

—

Active return over the benchmark per unit of tracking error

—

Annualized std dev of fund-minus-benchmark returns

—

Fund's share of benchmark gains in up months (100 = matches index)

—

Fund's share of benchmark losses in down months (lower is better)

—

Computed vs the Nifty 500 price index — the closest match to this fund's mandate. Needs ~3 years of history; a low R² means the fund tracks the index loosely.

Not sure what a figure means? The glossary explains every metric, and the methodology shows the formulas.

Backtest this fund

What a SIP or one-time investment would have grown to over this fund’s real NAV history.

Monthly investment (₹)

Period

Invested

₹3.60L

Current value

₹5.17L

Absolute

+43.61%

XIRR

+26.33%

Value vs. invested

36 monthly installments of ₹10,000 into UTI Long Term Advantage Fund Series VII, valued at the latest NAV. XIRR annualizes for each installment’s timing.

Calendar-year returns

What the fund actually returned in each year, not the smoothed average.

Year	Fund	Nifty 500	Diff
2021part	+25.68%	—	—
2020	+20.14%	+16.67%	+3.47%
2019	-5.10%	+7.66%	-12.76%
2018part	-8.22%	—	—

January–December, from this fund's NAV history. Absolute return, not annualised. “part” marks a year the fund didn't run end to end — its first year, the current year so far, or one it stopped reporting in; those years show no benchmark comparison.

History points

861

Expense ratio

—

AUM

₹196.14Cr

Portfolio turnover

14%

Exit load

Nil

P/E ratio

20.8

P/B ratio

2.9

Avg market cap

₹4,46,751Cr

P/E & P/B are portfolio-weighted harmonic means across 54 of 58 equity holdings (86% of the portfolio); loss-making companies are excluded.

Taxation

Taxed as equity

This is an equity-oriented fund (≥65% in Indian equities), so gains get the concessional capital-gains rates below — they do not add to your income-tax slab.

Short-term (STCG)

20%

Held under 1 year

Flat, on the whole gain

Long-term (LTCG)

12.5%

Held 1 year or more

On gains above ₹1.25 L per financial year

Applies to capital gains on redemption. Excludes IDCW/dividend tax, STT, surcharge and cess, and pre-2018 equity grandfathering. For research only — consult a tax advisor before filing.

Market-cap allocation · AMFI bands, Jul 2026

Equity holdings by company size — 98% of the equity sleeve priced.

Large cap55.6%
Mid cap20.6%
Small cap23.8%

🚩Holdings under NSE surveillance (ASM)

1 holding — 0.52% of the portfolio — sit in stocks NSE currently lists under its Additional Surveillance Measure. ASM is an exchange response to unusual price or volume activity (higher margins, and trade-for-trade settlement at stage II), not a view on the company or on this fund.

Mtar Technologies LimitedLong-term · Stage IV0.52%

Source: NSE ASM list, matched to holdings by company name — a holding whose name differs from NSE's spelling may not be matched. BSE's separate list is not covered.

Worst falls, and the wait to get back

How far this fund has dropped from a high, and how long it took to reclaim it.

-42.6%30 Apr 2018 → 24 Mar 2020
Fell over 1.9 years, back to the old high on 04 Dec 2020 — 8 months under water after the low.
-7.8%15 Feb 2021 → 12 Apr 2021
Fell over 2 months, back to the old high on 24 May 2021 — 42 days under water after the low.

Measured on this fund’s own NAV history, peak to trough to the day it regained the peak. Falls shallower than 5% are left out. A recovery date is when the NAV got back, not when any particular investor did — that depends on when they bought.

Explore from here

Top holdings

HDFC Bank Ltd Bharti Airtel Ltd ICICI Bank Ltd State Bank of India ITC Ltd Axis Bank Ltd Crompton Greaves Consumer Electricals Ltd Cholamandalam Investment & Finance Company Ltd Infosys Ltd ICICI Prudential Life Insurance Company Ltd Eicher Motors Ltd Carborundum Universal Ltd

UTI in the news

Headlines about the fund house, not this scheme in particular — highlights only; tap through to read the full story at the source.

Run SIP calculator Add to compare

Returns and risk are computed from NAV history and may differ slightly from other portals due to methodology (rolling vs point-to-point, dividend treatment). For research only — not investment advice.

Frequently asked questions

What is the NAV of UTI Long Term Advantage Fund Series VII?

The last published NAV of UTI Long Term Advantage Fund Series VII was ₹13.18 per unit, on 24 Sep 2021. The scheme has not published a NAV since then — it has likely been merged, wound up or discontinued, so this figure is historical, not a current price.

What are the top holdings of UTI Long Term Advantage Fund Series VII?

UTI Long Term Advantage Fund Series VII's largest holdings are HDFC Bank Ltd (10.0%), Bharti Airtel Ltd (7.1%), ICICI Bank Ltd (7.1%), State Bank of India (6.5%) and ITC Ltd (6.0%). Holdings are disclosed monthly and change over time.

How risky is UTI Long Term Advantage Fund Series VII?

UTI Long Term Advantage Fund Series VII is rated moderate on SEBI's risk-o-meter and its worst peak-to-trough fall in our sample was -42.6%. Higher volatility means the NAV swings more; the drawdown shows how far it has fallen from a peak historically.

What is the benchmark of UTI Long Term Advantage Fund Series VII?

UTI Long Term Advantage Fund Series VII is benchmarked against the BSE 200 Total Return Index. Its alpha and beta on this page are measured against that index.

How is UTI Long Term Advantage Fund Series VII taxed?

UTI Long Term Advantage Fund Series VII is an equity-oriented fund, so its capital gains get concessional rates: short-term gains (units held under 1 year) are taxed at 20%, and long-term gains (held 1 year or more) at 12.5% above a ₹1.25 lakh per-year exemption. These rates apply on redemption and don't add to your income-tax slab.